Navigation Links
Parker Signs Licensing Agreement with Vanderbilt for Exoskeleton Technology and Targets Commercial Launch in 2014
Date:10/30/2012

CLEVELAND, Oct. 30, 2012 /PRNewswire/ -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it has signed an exclusive licensing agreement with Vanderbilt University for its exoskeleton technology, which allows individuals with severe spinal cord injury to walk and enhances rehabilitation for people who have suffered a stroke.  The agreement gives Parker exclusive rights to develop, manufacture and sell the device. Parker intends to invest in further development of the technology and establish a business unit targeting commercial launch of the exoskeleton device in 2014.

(Photo: http://photos.prnewswire.com/prnh/20121030/CL02182-a )
(Photo: http://photos.prnewswire.com/prnh/20121030/CL02182-b )
(Logo: http://photos.prnewswire.com/prnh/19990816/PHLOGO )

"This agreement offers Parker an exciting growth opportunity in the area of biomechanics," said Craig Maxwell, Vice President of Technology and Innovation for Parker.  "By leveraging our core motion and control technology, we are confident that we can take the company in new and exciting directions while improving the lives of people who experience mobility challenges.  Having studied the current state of the art, we believe the technology developed at Vanderbilt is far superior in terms of both design and functional performance. We are embarking on an aggressive development and launch plan to bring what was once thought of as science fiction into the marketplace."

The Parker exoskeleton offers numerous advantages over existing technologies which are being tested in rehabilitation clinics.  The exoskeleton is 40-50% lighter th
'/>"/>

SOURCE Parker Hannifin Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Parker Creates Endowed Chair at Cleveland State University for Research in Human Motion and Control
2. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
3. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
4. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
5. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
6. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
7. H. D. Smith Signs Three Year Prime Vendor Agreement with PharmacyGPO Buying Group
8. Bacterin International Signs Its Third National GPO Contract with Novation
9. MusclePharm Signs Pro Baseball Rookie Phenom Bryce Harper As Sponsored Athlete
10. Masimo Signs Pronto-7™ Distribution Deal with Henry Schein
11. Unilife Signs Long-Term Supply Contract for the Unifill Prefilled Syringe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ... on its pipeline and new product development efforts. In ... initiate a Phase 2a study of AZ-002 (Staccato ... the management of patients with acute repetitive seizures. ... -based product candidates for development - AZ-008 and ...
(Date:7/31/2014)... -- UBM Medica US announces that Cancer Network ... exclusive slide shows dealing with communication in the oncology ... Cancer Network, the online home ... and podcasts about the latest clinical findings. Among the ... , End-of-life care is challenging for even the most ...
(Date:7/31/2014)... 31, 2014  Decision Resources Group,s experts ... by the Affordable Care Act (ACA), which ... pharmaceutical therapies. The ACA altered how Managed ... regulations and expanded access via government-supported programs. ... exchanges—state-based marketplaces set up by states or ...
Breaking Medicine Technology:Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4
... Untold Numbers of Consumers Still Left Disabled By Its ... GlaxoSmithKline, the maker of popular denture adhesives Poligrip and Super ... its denture adhesive products.  The pharmaceutical giant has added the potentially ... consuming large quantities of zinc over an extended period of time ...
... , , SHANGHAI , ... WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing ... announced that it will release financial results for the fourth quarter of ... 8, 2010 (which will be Tuesday morning, March 9, 2010 ...
Cached Medicine Technology:Leading Denture Cream Litigation Firm Welcomes GSK Announcement of Removal of Zinc From Its Denture Creams 2Leading Denture Cream Litigation Firm Welcomes GSK Announcement of Removal of Zinc From Its Denture Creams 3WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release 2WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release 3
(Date:8/1/2014)... at the University of California, San Diego School of ... in chili peppers produces chronic activation of a ... a reaction that ultimately reduces the risk of colorectal ... 1, 2014 issue of The Journal of Clinical ... TRPV1, was originally discovered in sensory neurons, where it ...
(Date:8/1/2014)... in regulating appetite and whole-body metabolism. A protein known ... food intake and body weight, but the identity of ... A new study in the Journal of ... type of neuron known as pro-opiomelanocortin (POMC) neurons is ... Sabrina Diano and colleagues at Yale University School of ...
(Date:8/1/2014)... Barbara Bronson Gray HealthDay Reporter ... obese and work in manufacturing jobs may have significantly less endurance ... a study of 32 people -- half were obese, half were ... times that were about 60 percent longer. Obesity also was ... Being older -- 50 to 65 years of ...
(Date:8/1/2014)... 1, 2014 (HealthDay News) -- The U.S. Food and ... new drug, Jardiance, to help fight type 2 diabetes. ... added to existing treatment regimens to control blood sugar ... Rosebraugh, director of the Office of Drug Evaluation II ... said in an agency statement. The FDA also ...
(Date:8/1/2014)... study, researchers at University Hospitals Rainbow Babies & Children,s ... at greater risk for death on a commercial airline ... worldwide between January 2010 and June 2013 and found ... age of 2. , The study was conducted ... of an in-flight pediatric fatality onboard commercial airline flights ...
Breaking Medicine News(10 mins):Health News:Pepper and halt: Spicy chemical may inhibit gut tumors 2Health News:Obesity Might Slow You Down at Work 2Health News:Obesity Might Slow You Down at Work 3Health News:FDA Approves New Type 2 Diabetes Drug 2Health News:New research characterizes in-flight pediatric deaths 2
... and areas for improvement in reform proposals for small businesses ... on Small Business and Entrepreneurship Chair Mary Landrieu, D-La., and ... to better understand the needs of small businesses in health ... those needs. , "We are here today to discuss one ...
... , WASHINGTON, Oct. 20 Speaker Nancy Pelosi, House ... Michigan held a press availability this afternoon ... the urgency of health insurance reform for children with pre-existing ... and Jessica Segal of Texas told ...
... benefits patients, study shows , TUESDAY, Oct. 20 (HealthDay ... patients when used up to 4.5 hours after a ... provide further evidence to increase the tPA treatment window ... Previously published findings from the ECASS III study indicated ...
... 20 (HealthDay News) -- In an effort to reduce ... Reproductive Medicine has revised its recommendations on the number ... fertilization procedures. , The society reports that the ... For one, it says that doctors should only use ...
... Body Worlds 2 & The Brain ... October 17, and will be one of many points of ... of scientific treasures. The second-largest medical research and education center ... medical, anatomical and scientific sites--from the nation,s first hospital and ...
... patients in U.S. hospitals fail to get recommended therapy, ... A recommended treatment for heart failure is underused in ... of aldosterone antagonist therapy in patients with heart failure ... failure guidelines established by the American College of ...
Cached Medicine News:Health News:Landrieu, Snowe Champion Small Business Health Care Reform Efforts 2Health News:Pelosi Remarks at Press Availability with Easter Seals on Benefits of Health Reform for Children 2Health News:Pelosi Remarks at Press Availability with Easter Seals on Benefits of Health Reform for Children 3Health News:Stroke Treatment Window May Allow a Bit More Time 2Health News:New IVF Guidelines Aim to Reduce Multiple Births 2Health News:Paging All Science and Medical Mavens: Get To Philadelphia Stat for Body Worlds and Beyond 2Health News:Paging All Science and Medical Mavens: Get To Philadelphia Stat for Body Worlds and Beyond 3Health News:Paging All Science and Medical Mavens: Get To Philadelphia Stat for Body Worlds and Beyond 4Health News:Heart Failure Treatment Underused 2
Irrigating Cystotome, formed, 23 g., 12 mm curved tip. Overall length 14 mm. 5/box....
Peribulbar Needle, 25 g. Atkinson style bevel. Overall length 31 mm. 5/box....
Scleral Blade tip 5700 style, straight. Dimensions: 15.2 mm (L) x 3.4 mm (W). Cut: 2.7 mm....
Blade tip handle....
Medicine Products: